Skip to content
  • Sunday, 26 July 2026
  • 2:48 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Groundbreaking Study Reveals Psilocybin Reduces Aggression and Activity in Mangrove Rivulus Fish, Opening New Avenues for Neuropsychiatric Research
Biotech & Genetic Research

Groundbreaking Study Reveals Psilocybin Reduces Aggression and Activity in Mangrove Rivulus Fish, Opening New Avenues for Neuropsychiatric Research

Jia Lissa May 15, 2026 0

A pioneering study has demonstrated that psilocybin, the psychoactive compound found in "magic mushrooms," can significantly reduce aggression and activity…

Read More
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Apr 4, 2026 0

For decades, successive waves of antidepressants have promised relief to millions suffering from mood disorders, yet the landscape for those…

Read More
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Mar 27, 2026 0

For decades, the medical community has grappled with the persistent challenge of mood disorders, offering successive waves of antidepressants that,…

Read More
Laboratory Automation & Robotics

First Phase 3 psilocybin data clears the bar for treatment-resistant depression, but how high was the bar?

Lana Keisha Mar 20, 2026 0

The landscape of mental health treatment witnessed a significant development on February 17, 2026, as Compass Pathways, a leading mental…

Read More

Posts pagination

1 2
Molecular Switch Discovery Unlocks New Potential for Blood Stem Cell Regeneration and Bone Marrow TransplantsNature’s Proton Highway Revealed: Scientists Unravel Molecular Secrets of Charge Transport in Biological Systems and BeyondLilly’s plans to buy CAR-T firm Kelonia in deal worth up to $7 billion. Can its deal spree avoid Pfizer’s fate?OpenCode Plugins Revolutionize AI-Assisted Coding, Empowering Developers with Enhanced Functionality and Customization.
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ